Article PDF
Avoid common mistakes on your manuscript.
References
Herings RMC, Stricker BHC. Bromocriptine and suppression of postpartum lactation. The incidence of adverse cardiovascular effects in women of child-bearing age. Pharm World Sci 1995;17:133–7.
US Food and Drug Administration. Sandoz Pharmaceutical Corp.: Bromocriptine mesylate (Parlodel); withdrawal of approval of the indication for the prevention of physiological lactation. Fed Reg 1995;60:3404–5.
Health Canada, Drugs Directorate. Bromocriptine and lactation suppression. Can Adverse Drug React Newsletter 1995;5:66–7.
US Food and Drug Administration. Sandoz Pharmaceutical Corp.: Bromocriptine mesylate (Parlodel) for the prevention of physiological lactation; opportunity for a hearing on a proposal to withdraw of approval of the indication. Fed Reg 1994;59:43347–52.
McCarthy M. Bromocriptine not for lactation suppression. Lancet 1994;344:602.
Rothman KJ, Funch DP, Dreyer NA. Bromocriptine and puerperal seizures. Epidemiology 1990; 1:232–8.
Watson DL, Bhatia RK, Norman GS, Brindley BA, Sokol RJ. Bromocriptine mesylate for lactation suppression: a risk for postpartum hypertension? Obstet Gynecol 1989;74:448–51.
Mallarkey G. Bromocriptine in lactation suppression: is there cause for concern? Curr Ther 1995:103–6.
Fournié A, Graile V, Montastruc JL. Bromocriptine, lactation inhibition and pharmacovigilance. J Gynecol Obstet Biol Reprod 1994;23:129–30.
Moride Y, Haramburu F, Bégaud B. Assessment of under-reporting of adverse events in pharmacovigilance. Pharmacoepidemiol Drug Saf 1994;3:S73.
Bromocriptine (Parlodel®) niet voor lactatieremming [Bromocriptine not for lactation suppression]. Geneesmiddelenbulletin 1994;28:84–5.
Zerebrale und kardiovaskulare Storwirkungen nach Abstillen met Bromocriptin (Pravidel). Arznei-telegramm 1995;3:27.
Mignot G. Inhibition de la lactation apres l'accounchement. Rev Prescrire 1995;15:440–5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Jong-van den Berg, L., Mintzes, B. Bromocriptine and lactation suppression: Are the risks acceptable?. Pharm World Sci 17, 93–95 (1995). https://doi.org/10.1007/BF01872384
Issue Date:
DOI: https://doi.org/10.1007/BF01872384